Product Alert
<ѻý>FDA Blocks Sale of Supplements for Parkinson's and Alzheimer'sѻý>
WASHINGTON -- The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson's disease, Alzheimer's disease, and a number of other neurological disorders.
Sep 16, 2011
<ѻý>Consumer Group Urges Boxed Warning for PPIsѻý>
Citing research showing that withdrawal of proton pump inhibitors (PPIs) leads to severe rebound acid secretion -- potentially leaving patients permanently dependent on the drugs -- the consumer group Public Citizen has told the FDA that it should require black-box warnings with the drugs.
Aug 23, 2011